Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer-Reference-Cited by-同舟云学术

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

Published:1997-11-19 Issue:22 Volume:89 Page:1673-1682
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Fisher B.,Dignam J.,Emir B.,Bryant J.,DeCillis A.,Wolmark N.,Wickerham D. L.,Dimitrov N. V.,Abramson N.,Atkins J. N.,Shibata H.,Deschenes L.,Margolese R. G.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference17 articles.

1. Adjuvant Chemotherapy for Breast Cancer

2. A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors

3. A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

4. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.

Cited by 436 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center;Pathology and Oncology Research;2024-04-16

2. Young Age as a Predictor of Chemotherapy Recommendation and Treatment in Breast Cancer: A National Cancer Database Study;Journal of Surgical Research;2024-04

3. Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment. A review;Journal of Modern Oncology;2024-03-05

4. A Public Health Emergency;Obstetrics and Gynecology Clinics of North America;2024-03

5. Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast Cancer;2024-02-09